Skip to main content

Table 2 Hematological assessment of the studied groups (n = 120)

From: Evaluation of platelets activity and reactivity as risk factors for acute ischemic non-embolic stroke in young adults

Laboratory investigations

Patients without risk factors cryptogenic (A1) (n = 37)

Patients with risk factors (A2) (n = 23)

Controls (healthy) (n = 60)

Test value

p-value

Post hoc between group A1 and A2

HB (g/dl)

Mean ± SD

12.8 ± 1.5

12.3 ± 2.7

12.6 ± 1.8

F = 0.238

0.78

0.97

Range

9.5–16.2

8.2–16.5

9.2–16.1

WBC X 103/μL

Mean ± SD

7.94 ± 7.94

8.43 ± 3.3

6.26 ± 2.0

F = 8.87

< 0.001*

0.74

Range

3.77–13.5

4.5–16.75

4.32–10

PLTs X103/μL

Mean ± SD

264 ± 78.645

270 ± 101.89

241 ± 92.82

F = 1.21

0.30

0.964

Range

130–446

95–493

493–600

MPV (fl)

Mean ± SD

10.6 ± 1.5

10.9 ± 1.6

9.3 ± 1.7

F = 11.81

< 0.001*

0.781

Range

8.5–14.2

8.4–14.5

6.0–12.9

PDW (fl)

Mean ± SD

13.6 ± 2.9

13.5 ± 1.9

11.9 ± 1.9

F = 8.75

< 0.001*

0.6124

Range

9.5–22

10.5–16.9

9.4–20.7

L-PCR (%)

Mean ± SD

29.4 ± 5.1

26.4 ± 4.9

28.9 ± 6.1

F = 2.14

0.542

0.12

Range

15.4–38.1

19.5–41.9

18.4–47.9

  1. *One-way ANOVA test (F) is statistically significant at level of significance of 95% (p < 0.05). MPV mean platelet volume, PDW platelet distribution width, L-PCR large platelet cell ratio, HB hemoglobin, WBC white blood cells, PLT = platelet, MPV mean platelet volume, PDW platelet distribution width, L-PCR large platelet cell ratio
  2. bold indicates statistically significant relation
  3. italic indicates the type of the test used